Same Drug Class

Methotrexate vs Rituximab

Methotrexate vs Rituximab: Overview

This comparison examines the pharmacological differences between Methotrexate and Rituximab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Methotrexate — Small molecule; Rituximab — Antibody.